메뉴 건너뛰기




Volumn 72, Issue SUPPL. 243, 2012, Pages 129-135

When should we measure Vitamin D concentration in clinical practice?

Author keywords

25 hydroxyvitamin D; Chronic kidney disease; Osteoporosis; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

EID: 84860358760     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2012.682888     Document Type: Article
Times cited : (34)

References (44)
  • 1
    • 79960104336 scopus 로고    scopus 로고
    • Evaluation, treatment and prevention of vitamin D defi ciency: An Endocrine Society clinical practice guideline
    • Holick M, Binkley N, Bischoff-Ferrari H,Gordon C, Hanley D, et al. Evaluation, treatment and prevention of vitamin D defi ciency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-1930.
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 1911-1930
    • Holick, M.1    Binkley, N.2    Bischoff-Ferrari, H.3    Gordon, C.4    Hanley, D.5
  • 2
    • 78650886291 scopus 로고    scopus 로고
    • The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know
    • Ross C, Manson JE, Abrams S, Aloia J, Brannon P, Clinton S, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab 2011;96:53-58.
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 53-58
    • Ross, C.1    Manson, J.E.2    Abrams, S.3    Aloia, J.4    Brannon, P.5    Clinton, S.6
  • 3
    • 79955963332 scopus 로고    scopus 로고
    • Vitamin D nutrition is at a crossroads
    • Norman A. Vitamin D nutrition is at a crossroads. Public Health Nutrition 2011;14:750-751.
    • (2011) Public Health Nutrition , vol.14 , pp. 750-751
    • Norman, A.1
  • 7
    • 3042636277 scopus 로고    scopus 로고
    • Why the optimal requirement for vitamin D3 is probably much higher than what is offi cially recommended for adults
    • Vieth R. Why the optimal requirement for vitamin D3 is probably much higher than what is offi cially recommended for adults. J Steroid Biochem Mol Biol 2004;89: 575-579.
    • (2004) J Steroid Biochem Mol Biol , vol.89 , pp. 575-579
    • Vieth, R.1
  • 10
    • 77956415589 scopus 로고    scopus 로고
    • Vitamin D in adult health and disease: A review and guideline statement from Osteoporosis Canada
    • Hanley D, Cranney A, Jones G, Whiting S, Leslie W, Cole D, et al. Vitamin D in adult health and disease: A review and guideline statement from Osteoporosis Canada. CMAJ 2010;182:E610-E618.
    • (2010) CMAJ , vol.182
    • Hanley, D.1    Cranney, A.2    Jones, G.3    Whiting, S.4    Leslie, W.5    Cole, D.6
  • 11
    • 77956182419 scopus 로고    scopus 로고
    • Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice
    • Souberbielle JC, Body JJ, Lappe J, Plebani M, Schoenfeld Y, Wang T, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmunity Reviews 2010; 9:709-715.
    • (2010) Autoimmunity Reviews , vol.9 , pp. 709-715
    • Souberbielle, J.C.1    Body, J.J.2    Lappe, J.3    Plebani, M.4    Schoenfeld, Y.5    Wang, T.6
  • 13
    • 53749085098 scopus 로고    scopus 로고
    • Vitamin D in health and disease
    • Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol 2008;3:1535-1541.
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1535-1541
    • Heaney, R.P.1
  • 14
    • 82255196832 scopus 로고    scopus 로고
    • A systematic review and meta-regression analysis of the vitamin D intake-serum 25-hydroxyvitamin D relationship to inform European recommendations
    • Cashman K, Fitzgerald A, Kiely M, Seamans K. A systematic review and meta-regression analysis of the vitamin D intake-serum 25-hydroxyvitamin D relationship to inform European recommendations. Br J Nutr 2011;106: 1617-1627.
    • (2011) Br J Nutr , Issue.106 , pp. 1617-1627
    • Cashman, K.1    Fitzgerald, A.2    Kiely, M.3    Seamans, K.4
  • 16
    • 80053636651 scopus 로고    scopus 로고
    • Association between vitamin D and risk of colorectal cancer: A systematic review of prospective studies
    • Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H. Association between vitamin D and risk of colorectal cancer: A systematic review of prospective studies. J Clin Oncol 2011;29: 3775-3782.
    • (2011) J Clin Oncol , vol.29 , pp. 3775-3782
    • Ma, Y.1    Zhang, P.2    Wang, F.3    Yang, J.4    Liu, Z.5    Qin, H.6
  • 17
    • 33845720114 scopus 로고    scopus 로고
    • Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis
    • Munger K, Levin L, Hollis B, Howard N, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-28 38.
    • (2006) JAMA , vol.296 , pp. 2832-2838
    • Munger, K.1    Levin, L.2    Hollis, B.3    Howard, N.4    Ascherio, A.5
  • 19
    • 34447514029 scopus 로고    scopus 로고
    • Vitamin D defi ciency
    • Holick MF. Vitamin D defi ciency. N Engl J Med. 2007; 357:266-81.
    • (2007) N Engl J Med , vol.357 , pp. 266-281
    • Holick, M.F.1
  • 20
    • 33847612366 scopus 로고    scopus 로고
    • How to select the doses of vitamin D in the management of osteoporosis
    • Bischoff-Ferrari H. How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 2007;18: 401-407.
    • (2007) Osteoporos Int , vol.18 , pp. 401-407
    • Bischoff-Ferrari, H.1
  • 22
    • 0037215304 scopus 로고    scopus 로고
    • Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol
    • Heaney R, Davies M, Chen TC, Holick M, Barger-Lux J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-210.
    • (2003) Am J Clin Nutr , vol.77 , pp. 204-210
    • Heaney, R.1    Davies, M.2    Chen, T.C.3    Holick, M.4    Barger-Lux, J.5
  • 23
    • 55949115834 scopus 로고    scopus 로고
    • Secondary hyperparathyroidism in primary osteoporosis and osteopenia: Optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be suffi cient for correction
    • Yendt E, Kovacs K, Jones G. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: Optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be suffi cient for correction. Clinical Endocrinology 2008;69:855-863.
    • (2008) Clinical Endocrinology , vol.69 , pp. 855-863
    • Yendt, E.1    Kovacs, K.2    Jones, G.3
  • 26
    • 70349857820 scopus 로고    scopus 로고
    • Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials
    • Bischoff-Ferrari H, Dawson-Hughes B, Staehelin HB, Orav J, Stuck A, Theiler R, et al. Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials. BMJ 2009;339:b3692.
    • (2009) BMJ , vol.339
    • Bischoff-Ferrari, H.1    Dawson-Hughes, B.2    Staehelin, H.B.3    Orav, J.4    Stuck, A.5    Theiler, R.6
  • 27
    • 77953443605 scopus 로고    scopus 로고
    • Bone mineralization defects and vitamin D defi ciency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients
    • Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, et al. Bone mineralization defects and vitamin D defi ciency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 2010;25:305-312.
    • (2010) J Bone Miner Res , vol.25 , pp. 305-312
    • Priemel, M.1    Von Domarus, C.2    Klatte, T.O.3    Kessler, S.4    Schlie, J.5    Meier, S.6
  • 28
    • 79951675673 scopus 로고    scopus 로고
    • Vitamin D insuffi ciency defi ned by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D3 supplementation load in Japanese patients
    • Okazaki R, Sugimoto T, Kaji H, Fujii Y, Shiraki M, Inoue D, et al. Vitamin D insuffi ciency defi ned by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D3 supplementation load in Japanese patients. J Bone Miner Metab 2011;29:103-110.
    • (2011) J Bone Miner Metab , vol.29 , pp. 103-110
    • Okazaki, R.1    Sugimoto, T.2    Kaji, H.3    Fujii, Y.4    Shiraki, M.5    Inoue, D.6
  • 29
    • 77954546834 scopus 로고    scopus 로고
    • Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: Impact on the clinical cut-offs
    • Cavalier E, Rozet E, Gadisseur R, Carlisi A, Monge M, Chapelle JP, et al. Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: Impact on the clinical cut-offs. Osteoporos Int 2010;21:1047-1051.
    • (2010) Osteoporos Int , vol.21 , pp. 1047-1051
    • Cavalier, E.1    Rozet, E.2    Gadisseur, R.3    Carlisi, A.4    Monge, M.5    Chapelle, J.P.6
  • 30
  • 31
    • 84858054171 scopus 로고    scopus 로고
    • Do glucocorticoids alter vitamin D status? A systematic review with meta-analyses of observational studies
    • in press
    • Davidson Z, Walker K, Truby H. Do glucocorticoids alter vitamin D status? A systematic review with meta-analyses of observational studies. J Clin Endocrinol Metab 2012;97 (in press).
    • (2012) J Clin Endocrinol Metab , pp. 97
    • Davidson, Z.1    Walker, K.2    Truby, H.3
  • 32
    • 56749102955 scopus 로고    scopus 로고
    • Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis
    • Camacho P, Dayal A, Diaz J, Nabhan F, Agarwal M, Norton J, et al. Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis. J Clin Oncol 2008;26:5380-5385.
    • (2008) J Clin Oncol , vol.26 , pp. 5380-5385
    • Camacho, P.1    Dayal, A.2    Diaz, J.3    Nabhan, F.4    Agarwal, M.5    Norton, J.6
  • 33
    • 68949114585 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney diseasemineral and bone disorder (CKD-MBD
    • KDIGO. Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney diseasemineral and bone disorder (CKD-MBD). Kidney Int 2009; 79:S1-S130.
    • (2009) Kidney Int , vol.79
  • 34
    • 79251474745 scopus 로고    scopus 로고
    • Vitamin D supplementation in chronic kidney disease: A systematic review and meta-analysis of observational studies and randomized controlled trials
    • Kandula P, Dobre M, Schold JD, Schreiber M, Mehrotra R, Navaneethan S. Vitamin D supplementation in chronic kidney disease: A systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011;6:50-62
    • (2011) Clin J Am Soc Nephrol , vol.6 , pp. 50-62
    • Kandula, P.1    Dobre, M.2    Schold, J.D.3    Schreiber, M.4    Mehrotra, R.5    Navaneethan, S.6
  • 35
    • 71049186478 scopus 로고    scopus 로고
    • Strategy for vitamin D supplementation monthly cholecalciferol administration in hemodialysis patients: A simple and effi cient strategy for vitamin D supplementation
    • Jean G, Souberbielle JC, Chazot C. Strategy for vitamin D supplementation. Monthly cholecalciferol administration in hemodialysis patients: A simple and effi cient strategy for vitamin D supplementation. Nephrol Dial Transplant 2009;24: 3799-3805.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 3799-3805
    • Jean, G.1    Souberbielle, J.C.2    Chazot, C.3
  • 36
    • 77952316154 scopus 로고    scopus 로고
    • Cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, infl ammation, and cardiac dimensions parameters
    • Matias PJ, Jorge C, Ferreira C, Borges C, Aires I, Amaral T, et al. Cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, infl ammation, and cardiac dimensions parameters. Clin J Am Soc Nephrol 2010;5:905-911.
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 905-911
    • Matias, P.J.1    Jorge, C.2    Ferreira, C.3    Borges, C.4    Aires, I.5    Amaral, T.6
  • 37
    • 61349169061 scopus 로고    scopus 로고
    • Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients
    • Courbebaisse M, Thervet E, Souberbielle JC, Zuber J, Eladari D, Martinez F, et al. Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int 2009;75:646-651.
    • (2009) Kidney Int , vol.75 , pp. 646-651
    • Courbebaisse, M.1    Thervet, E.2    Souberbielle, J.C.3    Zuber, J.4    Eladari, D.5    Martinez, F.6
  • 38
    • 80051919112 scopus 로고    scopus 로고
    • Vitamin D status and mortality risk in CKD: A metaanalysis of prospective studies
    • Pilz S, Iodice S, Zittermann A, Grant W, Gandini S. Vitamin D status and mortality risk in CKD: A metaanalysis of prospective studies. Am J Kidney Dis 2011;58: 374-382.
    • (2011) Am J Kidney Dis , vol.58 , pp. 374-382
    • Pilz, S.1    Iodice, S.2    Zittermann, A.3    Grant, W.4    Gandini, S.5
  • 40
    • 80053571782 scopus 로고    scopus 로고
    • Oral cholecalciferol decreases albuminuria and urinary TGF- 1 in patients with type 2 diabetic nephropathy on established renin-angiotensin- Aldosterone system inhibition
    • Kim MJ, Frankel A, Donaldson M, Darch S, Pusey C, Hill P, et al. Oral cholecalciferol decreases albuminuria and urinary TGF- 1 in patients with type 2 diabetic nephropathy on established renin-angiotensin- Aldosterone system inhibition. Kidney Int 2011;80:851-860.
    • (2011) Kidney Int , vol.80 , pp. 851-860
    • Kim, M.J.1    Frankel, A.2    Donaldson, M.3    Darch, S.4    Pusey, C.5    Hill, P.6
  • 41
    • 17844392085 scopus 로고    scopus 로고
    • Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insuffi ciency
    • Grey A, Lucas J, Horne A, Gamble G, Davidson J, Reid I. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insuffi ciency. J Clin Endocrinol Metab 2005;90:2122-2126.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 2122-2126
    • Grey, A.1    Lucas, J.2    Horne, A.3    Gamble, G.4    Davidson, J.5    Reid, I.6
  • 43
    • 59749089672 scopus 로고    scopus 로고
    • Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the third international workshop
    • Eastell R, Arnold A, Brandi ML, Brown E, D' A mour P, Hanley D, et al. Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94: 340-350.
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 340-350
    • Eastell, R.1    Arnold, A.2    Brandi, M.L.3    Brown, E.4    D'Amour, P.5    Hanley, D.6
  • 44
    • 34547765487 scopus 로고    scopus 로고
    • Normocalcemic primary hyperparathyroidism: Further characterization of a new clinical phenotype
    • Lowe H, McMahon DJ, Rubin M, Bilezikian J, Silverberg S. Normocalcemic primary hyperparathyroidism: Further characterization of a new clinical phenotype. J Clin Endocrinol Metab 2007;92:3001-3005.
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 3001-3005
    • Lowe, H.1    McMahon, D.J.2    Rubin, M.3    Bilezikian, J.4    Silverberg, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.